Search

everythinglearnresearchcommunity

for

Search:↓

Scalp melanoma is often diagnosed late in people with hair loss, leading to worse outcomes.

Human skin responds to light with protective mechanisms, but more research is needed to understand these processes and their implications for health and therapy.

Hair follicle cells resist turning into skin cells.

Telomerase-positive cells are mainly in the bulb matrix and outer root sheath of hair follicles.

UVB radiation harms hair growth and health, causing cell death and other changes in human hair follicles.

Estrogens and progesterone are key in regulating melasma pigmentation.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Finasteride can cause melasma, especially in people with darker skin.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

The PML protein helps prevent skin cancer in mice.

Researchers created artificial human skin using special cells, which could help treat skin conditions like albinism and vitiligo.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Melatonin helps hair grow by activating a specific signaling pathway.

Sox9 is crucial for hair follicle stem cells to become melanocytes instead of glial cells.

The enzyme 25 Hydroxyvitamin D 1 α-Hydroxylase is essential for healthy skin and recovery after skin damage.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Mutations in the hairless protein gene cause hair loss.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

SASH1 gene mutations are linked to various inherited skin pigmentation disorders.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

The treatment improved hair color in most vitiligo patients without major side effects.

Mast cells might contribute to hair loss by causing skin thickening.

Removing β-catenin in certain stem cells causes hair whitening and pigmentation issues.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

Glycine reduces skin pigmentation by lowering melanin production.